In light of the rapidly evolving economic, policy, and regulatory landscape surrounding antibiotics, we at Revagenix believe it’s crucial to participate and engage in dialogue with the broad range of stakeholders, and to lead the way for change. Whether it’s nucleating the Antimicrobial Innovation Alliance (AIA), or engaging with journalists to raise awareness of the antimicrobial resistance crisis, the Revagenix team is on the front lines telling our story, advocating, and working collaboratively toward a sustainable antibiotic pipeline.